Immunomodulatory DC vaccines to target prostate cancer
GIMI-IRB-25002
Phase 2 mab active
Quick answer
Immunomodulatory DC vaccines to target prostate cancer for Prostate Cancer Indications is a Phase 2 program (mab) at Shenzhen Second People's Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shenzhen Second People's Hospital
- Indication
- Prostate Cancer Indications
- Phase
- Phase 2
- Modality
- mab
- Status
- active